12:00 AM
 | 
Oct 12, 2015
 |  BC Week In Review  |  Company News  |  Deals

Asuragen, Illumina deal

The companies partnered to develop and commercialize sequencing-based companion diagnostics. Asuragen will use its Quantidex NGS product platform to...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >